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Papillary mucinous cystadenocarcinoma: rare malignant tumor in minor 
salivary gland
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ABSTRACT
Clinical case description of a papillary mucinous cystadenocarcinoma, extremely rare malignant tumor in the salivary gland and difficult 
to diagnose, in geriatric patient. Patient with 86 years old was referred for treatment with nodular lesion on the inner side of left lower 
lip extending to the bucal mucosa, without any clinical appearances of malignancy. The lesion was asymptomatic, had flabby consistency 
and slow growth. Despite the favorable clinical features, after surgical removal, was diagnosed as papillary mucinous papillary mucinous 
cystadenocarcinoma. Nonetheless, the cellular atypia found was considered to be mild and immunohistochemical evaluation the reaction to 
Ki-67 was low, indicating a low rate of proliferation of the tumor. Medical evaluation confirmed the absence of systemic disorders or distant 
metastases. Although it is a malignant lesion, due to low degree of proliferation of lesion and the careful follow-up carried out, there was a 
favorable evolution after conservative treatment in a follow-up period of 11 years and six months.
Indexing terms: Cystadenocarcinoma. Neoplasm. Salivary gland. 
RESUMO
Descrição do caso clínico de um cistadenocarcinoma papilar mucinoso, tumor maligno extremamente raro em glândula salivar e de difícil 
diagnóstico, em um paciente geriátrico. Paciente com 86 anos foi encaminhado para tratamento com lesão nodular na parte interna do 
lábio inferior do lado esquerdo estendendo-se para a mucosa jugal sem qualquer aspecto clínico de malignidade. A lesão era assintomática, 
apresentava consistência flácida e crescimento lento. Apesar das características clínicas favoráveis, após a remoção cirúrgica, o diagnóstico 
foi de cistadenocarcinoma papilar mucinoso. Entretanto, a atipia celular encontrada foi considerada leve e a reação imunohistoquímica para 
o Ki67 baixa, indicando uma baixa taxa de proliferação do tumor. A avaliação médica confirmou a ausência de transtornos sistêmicos e de 
metástases a distância. Apesar de se tratar de uma lesão maligna, devido ao baixo grau de proliferação do tumor e o acompanhamento 
cuidadosos realizado houve uma evolução favorável após o tratamento conservador após um período de acompanhamento de 11 anos e 6 
meses.
Termos de indexação: Cistadenocarcinoma. Neoplasias. Glândulas salivares.
on cystadenocarcinomas described in the literature, 
the highest prevalence is also observed in the major 
salivary glands3.
There are between 450 and 750 minor salivary 
glands distributed in the head and neck area4 and 
neoplasms affecting these structures are usually malignant. 
These tumors have enormous diversity in their morphology 
and appearance5. Such characteristics associated with 
oncologists' scarce clinical experience in this type of 
INTRODUCTION
Malignant tumors of the salivary glands are rare, 
comprising from 1 to 6% of all head and neck tumors 
and the parotid is most commonly affected, accounting 
for 70% of the lesions1. Papillary cystadenocarcinoma, 
in turn, comprises an extremely rare lesion, accounting 
for 0.5% of all epithelial lesions affecting the salivary 
glands2 and according to the second largest survey 
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injury complicate diagnosis and treatment, hindering the 
prognosis and becoming a real challenge for clinicians and 
pathologists1.
Minor salivary gland tumors are distributed in the 
upper aerodigestive tract, palate, paranasal sinuses, nasal 
cavity, tongue, gums, pharynx, larynx and trachea6 and 
comprise several subtypes5. However, most of these lesions 
are intraoral and appear as painless swelling. The presence 
of painful symptoms is more common in cases of lesions 
with malignant characteristic, but asymptomatic malignant 
tumors of minor salivary glands are not uncommon either7. 
Many malignant tumors of salivary glands 
are characterized by abundant secretion of mucin. 
Mucoepidermoid carcinoma, salivary duct carcinoma, 
and cystadenocarcinoma are part of this group of 
mucin-producing tumors, among others. Mucus is the 
predominant histological component of these lesions, and 
the ratio between extracellular mucin and epithelial portion 
is variable. Therefore, the confluence of characteristics 
between tumors associated with the rarity of the lesions 
make it difficult to perform an accurate diagnosis8. Among 
these lesions, cystadenocarcinoma stands out due to its 
rarity in the salivary gland with only a large series of 57 
cases described in the literature3. Thus, it is pertinent to the 
description of this clinical case.
CASE REPORT
Patient, 86 years old, male, with leukoderma, 
was referred for treatment with elevation on the inner 
side of left lower lip extending to the bucal mucosa. The 
lesion was asymptomatic and had flabby consistency on 
palpation and, according to the patient, slow growth has 
been observed for one year. Clinical evaluation identified 
a nodular lesion of sessile base, well-defined, covered by 
normal-colored mucosa, but it had a point of mucosal 
fluid drainage (Figure 1). 
Given the characteristics of the lesion without 
any clinical appearances of malignancy, excisional biopsy 
of the lesion was proposed under local anesthesia. For 
such, an incision was performed delimiting the nodule 
preceded by dissection and complete removal of the 
lesion (Figure 2). Despite the favorable clinical features, 
it was diagnosed papillary mucinous cystadenocarcinoma 
of low-grade malignancy. Microscopically, the lesion was 
described as having multiple cystic spaces surrounded 
by the papillary projections of the dysplastic epithelium 
(Figure 3). 
Figure 1. Injury covered by intact mucosa presenting point of mucosal fluid drain-
age.
Figure 2. Surgical wound after complete removal of the lesion.
Nonetheless, the cellular atypia found was 
considered to be mild. Immunohistochemical evaluation of 
the lesion was also performed, showing positive reaction 
to the markers CK7, CK18, CEA and negative reaction to 
CK14, CK20, TTF-1, and PSA. Furthermore, the reaction 
to Ki-67 was low, indicating a low rate of proliferation 
of the tumor. A strong staining for mucin was observed, 
revealing the key component of the tumor (Figure 4). 
At the postoperative period of 15 days, for suture 
removal, it was observed satisfactory repair. Medical 
evaluation confirmed the absence of systemic disorders 
or distant metastases. Clinical follow-up was carried out 
throughout 11 years and 6 months with periodic returns 
(Figures 5). During this period no recurrence or metastasis 
was observed.
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Figure 5. Sound appearance of the operated site in the follow-up of 11 years and 
6 months.
Figure 3. Surgical wound after complete removal of the lesion.
Figure 4. Strong staining by mucin showing the key component of the tumor.
DISCUSSION
Clinical characteristic of tumors of minor salivary 
glands appears to be quite variable. Most of the lesions 
are asymptomatic or with obvious symptoms for a short 
period in relation to the time they stay in the oral cavity7. In 
this clinical case, there was no history of painful symptoms, 
although the lesion had already been observed by the 
patient about 1 year ago. 
A conduct widely used in the treatment of salivary 
gland tumors is the 4 cm rule9. According to Speight & 
Barrett1, tumors smaller than 4 cm have higher survival 
rates and lower incidence of regional or distant metastases 
and in those cases, radiation therapy is not indicated. These 
reports in the literature could explain, in part, the absence 
of metastases and the high survival rate of the patient of 
this clinical case due to the small size of the tumor. 
According to Chandana & Conley6, tumors of 
minor salivary glands are most commonly presented as 
an asymptomatic volumetric increase of the ulcerated/
non-ulcerated mucosa. In most cases, papillary 
cystadenocarcinoma is asymptomatic and has slow 
growth10-11. The concerned clinical case was a painless 
nodule of sessile base, covered with normal and intact 
mucosa. In contrast, the tumor location in a minor salivary 
gland on the inner side of the lower lip may be considered 
atypical compared with the findings of Foss et al.3, where 
65% of cystadenocarcinomas were located in the major 
salivary glands, preferably in the parotid. In addition, 
most tumors of the minor salivary glands located in the 
lip affect the upper lip, and lower lip lesions in most cases 
correspond to simple mucocele1. The lesion site (lower lip) 
in this case report complies with the findings of Foss et al.3, 
who observed that most cystadenocarcinomas afflicting 
minor salivary glands (35%), affected the lips, followed by 
buccal mucosa, palate and tongue. 
 Papillary mucinous cystadenocarcinoma can be 
histologically described by the presence of large cystic 
spaces filled with mucus surrounded by exophytic papillary 
structures3. However, the presence of mucus and papillary 
projections is relatively common in lesions of salivary gland 
origin, which complicates the diagnosis12. Moreover, 
cystadenocarcinoma is generally well-defined and papillary 
or cribriform projections are present in 75% of cases. 
These projections are lined by small cubic cells, large cubic 
cells and columnar cells in 60%, 16% and 12% of cases, 
respectively, and a mixture of these cell types (12%) may 
still be observed3. Pleomorphism and atypical mitoses are 
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uncommon, but they have been reported in some cases11.
Therefore, this lesion is considered by WHO and 
several authors as of low-grade malignancy13. In this clinical 
case, papillary projections and cystic spaces were quite 
evident, resulting in the diagnosis of papillary mucinous 
cystadenocarcinoma. 
In addition to the assessment of the slices by 
staining with hematoxylin and eosin, which is still considered 
by some authors as the gold standard for the diagnosis of 
salivary gland, immunohistochemistry was also performed. 
According to Aloudah et al.11, immunohistochemistry is 
not very useful for the differential diagnosis of salivary 
gland neoplasms and there is still no cystadenocarcinoma-
specific antibody, however due to the rarity of the lesion, 
we chose to use various antibodies. However, there was 
low positivity to Ki-67, which means the tumor has a low 
proliferation rate and thus a low degree of malignancy10. 
Regarding the form of treatment, according to the 
guidelines of the National Comprehensive Cancer Network 
(NCCN), the first-line treatment for carcinoma of major 
and minor salivary glands is surgical excision14 which can 
be associated or not with radiation therapy5. In the case 
of low-grade cystadenocarcinoma, because of its indolent 
behavior and low malignant potential, local but complete 
excision appears to be sufficient3. 
 As for survival, Kruse et al.4, reported excellent 
healing rates when complete resection of the tumor 
is achieved with infrequent metastases. Regarding 
cystadenocarcinoma, according to a review of 57 cases 
performed by the Institute of Pathology of the Armed Forces 
(AFIP), most patients showed survival during a follow-up 
period of 59 months3. In this case report, an increased 
survival was observed, with more than 11 years of follow-
up after total excision of the lesion, which was carried out 
without safety margins due to benign clinical appearance 
of the lesion preoperatively. After the histopathological 
diagnosis of a malignant lesion, the patient underwent 
periodic medical/dental follow-up and no recurrence or 
metastasis was seen despite the conservative treatment 
performed. 
The incidence and mortality rates of salivary gland 
cancers vary per race and sex, and according to Swanson 
& Burns15, the average annual incidence of the disease 
for white males is 1.2 in every 100,000 inhabitants, while 
for black males is 1.0 in every 100,000 inhabitants. As for 
females, the incidence is 0.7 in every 100,000 inhabitants 
in both races, and despite the higher prevalence in men, 
the highest survival rates were observed in women. In 
the case of papillary mucinous cystadenocarcinoma, the 
highest prevalence occurs in adults, with a mean age of 
58.8 years old, showing a peak incidence in the eighth 
decade of life and with no difference in disease onset 
between the sexes3.The patient in this case is an 86-year-
old white male.
In this context, follow-up of patients who had 
salivary gland tumors is essential and aims at early 
recognizing relapses and identifying complications arising 
from the treatment8. Despite the cystadenocarcinoma 
described in this paper has a low degree of malignancy, 
the literature occasionally reports cases of recurrence 
(7.7%) and regional metastases (10%), therefore follow-
up of this kind of injury should not be considered less 
important2. The periodic returns are important especially 
in the first three years, since 70% of recurrences of minor 
salivary gland tumors occur in this period4. Follow-up visits 
should be scheduled periodically, according to the risk 
of disease recurrence and should be performed by head 
and neck surgeons or oncologists and dentists14. In this 
clinical case, the medical/dental follow-up over 10 years 
revealed no recurrences, metastases or other complications 
and, according to Gallego et al.12, in cases of low-grade 
cystadenocarcinoma, which is the lesion described in 
this case, annual reviews for a 5-year period seem to be 
sufficient.
CONCLUSION
Although it is a malignant lesion, due to low 
degree of proliferation of lesion and the careful follow-
up carried out, there was a favorable evolution after 
conservative treatment in a follow-up period of 11 years 
and six months.
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